Experimental non-transmissible marker vaccines for classical swine fever (CSF) by trans-complementation of E(rns) or E2 of CSFV.

scientific article published on February 2002

Experimental non-transmissible marker vaccines for classical swine fever (CSF) by trans-complementation of E(rns) or E2 of CSFV. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0264-410X(01)00497-2
P698PubMed publication ID11858861

P50authorPiet A van RijnQ41598182
René G.P.van GennipQ74520247
P2093author name stringA Bouma
R J M Moormann
M N Widjojoatmodjo
P2860cites workClassical swine fever virus leader proteinase Npro is not required for viral replication in cell cultureQ27469566
Classical swine fever virus E(rns) deletion mutants: trans-complementation and potential use as nontransmissible, modified, live-attenuated marker vaccinesQ27469643
cis- and trans-acting elements in flavivirus RNA replicationQ27469649
E2-p7 region of the bovine viral diarrhea virus polyprotein: processing and functional studiesQ27469693
Cytopathogenicity of classical swine fever virus caused by defective interfering particlesQ27478476
Classical swine fever virus: independent induction of protective immunity by two structural glycoproteinsQ27480305
Structural proteins of hog cholera virus expressed by vaccinia virus: further characterization and induction of protective immunityQ27486161
Live attenuated pseudorabies virus expressing envelope glycoprotein E1 of hog cholera virus protects swine against both pseudorabies and hog choleraQ27486212
Molecular characterization of pestivirusesQ29620899
Pseudorabies virus envelope glycoproteins gp50 and gII are essential for virus penetration, but only gII is involved in membrane fusionQ40063970
Chimeric classical swine fever viruses containing envelope protein E(RNS) or E2 of bovine viral diarrhoea virus protect pigs against challenge with CSFV and induce a distinguishable antibody responseQ40613736
Development of a classical swine fever subunit marker vaccine and companion diagnostic testQ40622391
Recombinant classical swine fever (CSF) viruses derived from the Chinese vaccine strain (C-strain) of CSF virus retain their avirulent and immunogenic characteristicsQ40624179
Determination of the onset of the herd-immunity induced by the E2 sub-unit vaccine against classical swine fever virusQ40628191
The classical swine fever epidemic 1997-1998 in The Netherlands: descriptive epidemiologyQ40628267
Classical swine fever in The Netherlands 1997-1998: a description of organisation and measures to eradicate the diseaseQ40628272
Efficacy and stability of a subunit vaccine based on glycoprotein E2 of classical swine fever virusQ40639488
Generation of cytopathogenic subgenomic RNA of classical swine fever virus in persistently infected porcine cell linesQ40641197
Infection with classical swine fever virus: effects on phenotype and immune responsiveness of porcine T lymphocytesQ40642235
An improved ELISA for the detection of serum antibodies directed against classical swine fever virusQ40642253
Inhibition of pestivirus infection in cell culture by envelope proteins E(rns) and E2 of classical swine fever virus: E(rns) and E2 interact with different receptorsQ40644907
Classical swine fever virus (CSFV) envelope glycoprotein E2 containing one structural antigenic unit protects pigs from lethal CSFV challengeQ40662007
Epitope mapping of envelope glycoprotein E1 of hog cholera virus strain BresciaQ40712752
A preliminary map of epitopes on envelope glycoprotein E1 of HCV strain BresciaQ40727836
Topographical and functional mapping of epitopes on hog cholera virus with monoclonal antibodies.Q40770174
The protective value of vaccine-induced neutralising antibody titres in swine feverQ40788758
Production of monoclonal antibodies against swine fever virus and their use in laboratory diagnosisQ40807127
Recovery of infectious classical swine fever virus (CSFV) from full-length genomic cDNA clones by a swine kidney cell line expressing bacteriophage T7 RNA polymerase.Q40817409
The neutralizing peroxidase-linked assay for detection of antibody against swine fever virusQ40828304
Enhanced protective response and immuno-adjuvant effects of porcine GM-CSF on DNA vaccination of pigs against Aujeszky's disease virus.Q40925612
An experimental marker vaccine and accompanying serological diagnostic test both based on envelope glycoprotein E2 of classical swine fever virus (CSFV).Q40967815
Isolation and characterization of cytopathogenic classical swine fever virus (CSFV).Q42989784
Interleukin-12 enhances the virus-specific interferon gamma response of pigs to an inactivated pseudorabies virus vaccineQ45755044
P433issue11-12
P407language of work or nameEnglishQ1860
P921main subjectclassical swine feverQ19000581
P304page(s)1544-1556
P577publication date2002-02-01
P1433published inVaccineQ7907941
P1476titleExperimental non-transmissible marker vaccines for classical swine fever (CSF) by trans-complementation of E(rns) or E2 of CSFV
P478volume20

Reverse relations

cites work (P2860)
Q40447606A common neutralizing epitope on envelope glycoprotein E2 of different pestiviruses: implications for improvement of vaccines and diagnostics for classical swine fever (CSF)?
Q39584650A mutant of Asia 1 serotype of Foot-and-mouth disease virus with the deletion of an important antigenic epitope in the 3A protein
Q38736128Alteration of a Second Putative Fusion Peptide of Structural Glycoprotein E2 of Classical Swine Fever Virus Alters Virus Replication and Virulence in Swine
Q47147214Animal health safety of fresh meat derived from pigs vaccinated against Classic Swine Fever
Q36177381Application of DIVA vaccines and their companion diagnostic tests to foreign animal disease eradication
Q40544173Attenuation of classical swine fever virus by deletion of the viral N(pro) gene
Q35030911Beta-actin interacts with the E2 protein and is involved in the early replication of classical swine fever virus.
Q40459043CP7_E2alf: a safe and efficient marker vaccine strain for oral immunisation of wild boar against Classical swine fever virus (CSFV).
Q40289853Characterization of C-strain "Riems" TAV-epitope escape variants obtained through selective antibody pressure in cell culture
Q39405057Chimeric classical swine fever (CSF)-Japanese encephalitis (JE) viral replicon as a non-transmissible vaccine candidate against CSF and JE infections
Q40113607Chimeric foot-and-mouth disease viruses: evaluation of their efficacy as potential marker vaccines in cattle
Q38326027Classical swine fever in pigs: recent developments and future perspectives
Q40073715Classical swine fever vaccines-State-of-the-art
Q38294607Classical swine fever virus E2 glycoprotein antigen produced in adenovirally transduced PK-15 cells confers complete protection in pigs upon viral challenge.
Q35226312Classical swine fever--an update
Q39489078Complementation studies with the novel "Bungowannah" virus provide new insights in the compatibility of pestivirus proteins
Q40499628Construction and evaluation of genetically engineered replication-defective porcine reproductive and respiratory syndrome virus vaccine candidates
Q47146243Control and eradication of Classic Swine Fever in wild boar
Q40383594Early onset and long lasting protection in pigs provided by a classical swine fever E2-vaccine candidate produced in the milk of goats.
Q38989117Effect of specific amino acid substitutions in the putative fusion peptide of structural glycoprotein E2 on Classical Swine Fever Virus replication
Q40428147Efficacy of intradermally administrated E2 subunit vaccines in reducing horizontal transmission of classical swine fever virus
Q35865567Establishment and characterization of an infectious cDNA clone of a classical swine fever virus LOM strain
Q39789272Generation of a candidate live marker vaccine for equine arteritis virus by deletion of the major virus neutralization domain
Q36827352Hemoglobin subunit beta interacts with the capsid protein and antagonizes the growth of classical swine fever virus.
Q40081087Identification and genetic characterization of classical swine fever virus isolates in Brazil: a new subgenotype.
Q40472508Identification of a novel virulence determinant within the E2 structural glycoprotein of classical swine fever virus.
Q58559646Identification of structural glycoprotein E2 domain critical to mediate replication of Classical Swine Fever Virus in SK6 cells
Q39615889Immunogenic and replicative properties of classical swine fever virus replicon particles modified to induce IFN-α/β and carry foreign genes
Q40163067Immunogenicity in Swine of Orally Administered Recombinant Lactobacillus plantarum Expressing Classical Swine Fever Virus E2 Protein in Conjunction with Thymosin α-1 as an Adjuvant
Q35530213Immunogenicity of recombinant classic swine fever virus CD8(+) T lymphocyte epitope and porcine parvovirus VP2 antigen coexpressed by Lactobacillus casei in swine via oral vaccination
Q39274226Interaction of CSFV E2 protein with swine host factors as detected by yeast two-hybrid system
Q45378278Marker vaccine potential of a foot-and-mouth disease virus with a partial VP1 G-H loop deletion
Q36578325Marker vaccine strategies and candidate CSFV marker vaccines
Q40147986Mutations in the carboxyl terminal region of E2 glycoprotein of classical swine fever virus are responsible for viral attenuation in swine.
Q27478046N-Linked Glycosylation Status of Classical Swine Fever Virus Strain Brescia E2 Glycoprotein Influences Virulence in Swine
Q34348810Newcastle disease virus (NDV) marker vaccine: an immunodominant epitope on the nucleoprotein gene of NDV can be deleted or replaced by a foreign epitope
Q36713635Novel marker vaccines against classical swine fever
Q40510511Oronasal vaccination with classical swine fever virus (CSFV) replicon particles with either partial or complete deletion of the E2 gene induces partial protection against lethal challenge with highly virulent CSFV.
Q40125019Packaged replicons of bovine viral diarrhea virus are capable of inducing a protective immune response
Q40409541Patterns of cellular gene expression in swine macrophages infected with highly virulent classical swine fever virus strain Brescia.
Q40363429Patterns of gene expression in swine macrophages infected with classical swine fever virus detected by microarray.
Q38266413RNA-based viral vectors
Q36931230Recent advances in the development of recombinant vaccines against classical swine fever virus: cellular responses also play a role in protection
Q40257221Sequencing approach to analyze the role of quasispecies for classical swine fever
Q27469449The E2 glycoprotein of classical swine fever virus is a virulence determinant in swine.
Q40655799The envelope glycoprotein E2 is a determinant of cell culture tropism in ruminant pestiviruses
Q35224851Time-calibrated phylogenomics of the classical swine fever viruses: genome-wide bayesian coalescent approach
Q36177358Vaccination against classical swine fever virus: limitations and new strategies
Q35576473Vaccinology of classical swine fever: from lab to field